Skip to content

Home
Treatments
- Tofacitinib (Xeljanz)
Experimental Treatments
About Us
Contact Us

Search for:

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

Search for:

Never miss another RA update.

* indicates required

Email Address *

First Name *

Last Name

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

Recent Posts

Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

June 12, 2017
Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

June 7, 2017
EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

June 5, 2017
DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

June 2, 2017

About Us
Contact Us
Terms of Service
Privacy Policy

Disclaimer:

Rheumatoid Arthritis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2024 All rights reserved.

We use cookies to enhance your experience on our website. Privacy PolicyAccept